EBA欧洲银行-MT_213800TC9PZRBHMJW403_TR_2016_13页_1mb

报告摘要

2016 EU-wide Transparency Exercise Summary - Medifin Holding Ltd

Core Information

Bank Name: Medifin Holding Ltd
LEI Code: 213800TC9PZRBHMJW403
Country Code: MT (Malta)

Own Funds - Transitional Period

Item	2015-12-31	2016-06-30	COREP Code	Regulation
A	226	237	C 0.00 (010,010)	Articles 4(118) and 72 of CRR
A.1	183	196	C 0.00 (020,010)	Article 50 of CRR
A.1.1	69	69	C 0.00 (030,010)	Articles 26(1) points (a) and (b), 27 to 29, 36(1) point (f) and 42 of CRR
A.1.2	89	86	C 0.00 (030,010)	Articles 26(1) point (c), 26(2) and 36 (1) points (a) and (f) of CRR
A.1.3	-11	-9	C 0.00 (018,010)	Articles 4(100), 26(1) point (d) and 36 (1) point (f) of CRR
A.1.4	35	51	C 0.00 (020,010)	Articles 4(117) and 26(1) point (e) of CRR
A.1.5	2	1	C 0.00 (010,010)	Articles 4(112), 26(1) point (f) and 36 (1) point (f) of CRR
A.1.6	0	0	C 0.00 (020,010)	Article 84 of CRR
A.1.7	0	0	C 0.00 (025,010)	Articles 32 to 35 of and 36 (1) point (f) of CRR
A.1.8	-1	-1	C 0.00 (030,010) + C 0.00 (030,010)	Articles 4(113), 36(1) point (b) and 37 of CRR; Articles 4(115), 36(1) point (b) and 37 point (a) of CRR
A.1.9	0	-4	C 0.00 (0370,010)	Articles 36(1) point (c) and 38 of CRR
A.1.10	0	0	C 0.00 (0380,010)	Articles 36(1) point (d), 40 and 159 of CRR
A.1.11	0	0	C 0.00 (0390,010)	Articles 4(109), 36(1) point (e) and 41 of CRR
A.1.12	0	0	C 0.00 (0430,010)	Articles 4(122), 36(1) point (g) and 44 of CRR
A.1.13	0	0	C 0.00 (0440,010)	Article 36(1) point (j) of CRR
A.1.14	0	0	C 0.00 (0450,010) + C 0.00 (0460,010) + C 0.00 (0470,010) + C 0.00 (0471,010) + C 0.00 (0472,010)	Articles 4(36), 36(1) point (i) and 89 to 91 of CRR; Articles 36(1) point (k) (i), 243(1) point (k), 244(1) point (k) (ii) and 258 of CRR; Articles 36(1) point (l) (i) and 379(3) of CRR; Articles 36(1) point (k) (iv) and 153(3) of CRR and Articles 36(1) point (k) (v) and 155(4) of CRR
A.1.14.1	0	0	C 0.00 (0460,010)	Articles 36(1) point (k) (i), 243(1) point (b), 244(1) point (b) and 258 of CRR
A.1.15	0	0	C 0.00 (0480,010)	Articles 4(27), 36(1) point (h); 43 to 46, 49 (2) and (3) and 79 of CRR
A.1.16	0	0	C 0.00 (0490,010)	Articles 36(1) point (c) and 38; Articles 48(1) point (a) and 48(2) of CRR
A.1.17	0	0	C 0.00 (0500,010)	Articles 4(27); 36(1) point (i); 43, 45; 47; 48(1) point (b); 49(1) to (3) and 79 of CRR
A.1.18	0	0	C 0.00 (0510,010)	Article 48 of CRR
A.1.19	0	0	C 0.00 (0524,010)	Article 3 CRR
A.1.20	0	0	C 0.00 (0529,010)	-
A.1.21	0	1	CA1 (1.1.1.6 + 1.1.1.8 + 1.1.1.26)	-
A.1.21.1	0	0	C 0.00 (0520,010)	Articles 483(1) to (3), and 484 to 487 of CRR
A.1.21.2	0	0	C 0.00 (0524,010)	Articles 479 and 480 of CRR
A.1.21.3	0	1	C 0.00 (0520,010)	Articles 469 to 472, 478 and 481 of CRR
A.2	0	0	C 0.00 (0530,010)	Article 61 of CRR
A.2.1	0	0	C 0.00 (0540,010) + C 0.00 (0670,010)	-
A.2.2	0	0	C 0.00 (0720,010)	-
A.2.3	0	0	C 0.00 (0690,010) + C 0.00 (0700,010) + C 0.00 (0710,010) + C 0.00 (0740,010) + C 0.00 (0744,010) + C 0.00 (0748,010)	-
A.2.4	0	0	C 0.00 (0660,010) + C 0.00 (0680,010) + C 0.00 (0730,010)	-
A.3	183	196	C 0.00 (015,010)	Article 25 of CRR
A.4	44	41	C 0.00 (0750,010)	Article 71 of CRR
A.4.1	44	41	C 0.00 (0760,010) + C 0.00 (0890,010)	-
A.4.2	0	0	C 0.00 (0910,010) + C 0.00 (0920,010) + C 0.00 (0930,010) + C 0.00 (0940,010) + C 0.00 (0950,010) + C 0.00 (0970,010) + C 0.00 (0974,010) + C 0.00 (0978,010)	-
A.4.3	0	0	C 0.00 (0880,010) + C 0.00 (0900,010) + C 0.00 (0960,010)	-

Capital Ratios (Transitional Period)

Item	2015-12-31	2016-06-30	COREP Code	Regulation
C.1	11.98%	11.63%	C33 (1)	-
C.2	11.98%	11.63%	C33 (3)	-
C.3	14.83%	14.03%	C33 (5)	-

CET1 Capital Fully Loaded

Item	2015-12-31	2016-06-30	COREP Code
D	183	195	[C.A.1-A.C.1-3-1.1+1-MUN(A.2+A.1.3- A.2.2- A.2.4+MIN(A.4+A.2.2+ A.4.3,0)]
E	11.98%	11.54%	[D.1]/[B.8.1]

Risk Exposure Amounts

Risk Exposure Type	2015-12-31 (mEUR)	2016-06-30 (mEUR)
Credit Risk	1,462	1,613
Securitisation and Re-securitisation (Banking Book)	0	0
Contributions to the Default Fund of a CCP	0	0
Other Credit Risk	1,462	1,613
Market Risk (Position, FX, Commodities)	0	0
Credit Valuation Adjustment	2	4
Operational Risk	63	72
Total Risk Exposure Amount	1,527	1,689

Profit and Loss (P&L)

P&L Item	2015-12-31 (mln EUR)	2016-06-30 (mln EUR)
Interest Income	59	22
Of which: Debt Securities Income	5	0
Of which: Loans and Advances Income	54	22
Interest Expenses	26	8
Of which: Deposits Expenses	23	7
Of which: Debt Securities Issued Expenses	3	1
Net Fee and Commission Income	0	1
Gains or (-) Losses on Derecognition	15	1
Gains or (-) Losses on Financial Assets Held for Trading	0	0
Gains or (-) Losses on Financial Assets Designated at FVTPL	1	0
Gains or (-) Losses from Hedge Accounting	1	0
Exchange Differences	1	-1
Net Other Operating Income/(Expenses)	-8	-1
Total Operating Income, Net	42	14
Administrative Expenses	24	8
Depreciation	1	0
Provisions or (-) Reversal of Provisions	0	0
Profit or (-) Loss Before Tax from Continuing Operations	17	5
Profit or (-) Loss After Tax from Continuing Operations	21	4
Profit or (-) Loss for the Year	21	4

Market Risk (Standardised Approach)

Item	2015-12-31 (mEUR)	2016-06-30 (mEUR)
Traded Debt Instruments	0	0
Of which: General Risk	0	0
Of which: Specific Risk	0	0
Equities	0	0
Foreign Exchange Risk	0	0
Commodities Risk	0	0
Total Risk Exposure Amount	0	0

Credit Risk - Standardised Approach

Counterparty Type	2015-12-31 (mEUR)	2016-06-30 (mEUR)
Central Governments or Central Banks	57	37
Regional Governments or Local Authorities	122	113
Public Sector Entities	119	111
Multilateral Development Banks	136	114
International Organisations	92	74
Institutions	158	168
Corporates	1,288	1,478
Of which: SME	0	0
Retail	4	3
Secured by Mortgages on Immovable Property	30	45
Exposures in Default	60	43
Items Associated with Particularly High Risk	1,462	1,613

Notes

The financial year for Medifin Holding Ltd ends in March, so P&L data for Dec 2015 represents 3 quarters, while data for Jun 2016 represents 1 quarter.
Original exposure is reported before considering credit conversion factors or credit risk mitigation techniques.
Total value adjustments and provisions per country of counterparty do not include securitisation exposures.

展开完整摘要